article thumbnail

Will India’s Permanent Establishment Tax Disrupt the Global Business Service Landscape? | Blog

Everest Group

In this blog, we delve into the impact of the Permanent Establishment (PE) tax within the realm of GBS. Indian transfer pricing regulations mandate that such transactions be conducted at arm’s length prices to prevent profit shifting.

article thumbnail

Decoding the Generative AI Buzz in Life Sciences | Blog

Everest Group

Despite challenges and regulations, the life sciences industry is actively exploring GAI’s possibilities. Although GAI can potentially disrupt the life sciences technology ecosystem in many significant ways, navigating the various risks and challenges that come with its implementation in this highly regulated industry will be critical.

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Life Sciences Supply Chain Visibility: A Strong Link in the Chain | Blog

Everest Group

Improved supply chain visibility can help global pharmaceutical and medical device suppliers overcome the many logistics challenges they face post-pandemic. Read our second blog in this series to learn more. The pharmaceutical industry experienced its largest theft in 2020 when $1.2 Reach out to panini.k@everestgrp.com

article thumbnail

Five Factors Transforming the Life Sciences Supply Chain and Creating IT Opportunities | Blog

Everest Group

Read this first part of our blog series to understand the shift that is underway. The worldwide value of pharmaceutical goods traded has grown six-fold in the past two decades from US$113 billion in 2000 to US$629 billion in 2019, according to the United Nations Comtrade Database. everestgrp.com and nisarg.shah@everestgrp.com.

article thumbnail

Generative AI in Clinical Development: Unlocking Possibilities and Addressing Challenges | Blog

Everest Group

Pharmaceutical enterprises must be aware of the following risks and biases so they can be prepared to address them: Data quality and bias : GAI relies on the quality of training data for generating meaningful outcomes. Ensuring compliance with the ambiguous regulations for digital technologies and AI in clinical development is complicated.

article thumbnail

Exploring the Potential of Generative AI in the Life Sciences Commercial Technology Landscape | Blog

Everest Group

However, given the strict industry regulations, human intervention/oversight remains essential for the overall usage of GAI. Exhibit 1 illustrates the key use cases that enterprises are striving to unlock in the near term.

article thumbnail

Mastering healthcare data governance with data lineage

IBM Services

For starters, healthcare organizations constantly encounter vast (and ever-increasing) amounts of highly regulated personal data. Healthcare organizations must adhere to data privacy regulations like HIPAA and GDPR. The healthcare industry faces arguably the highest stakes when it comes to data governance.